Hartfalen: epidemiologie, risicofactoren en toekomst

RIVM Rapport 260401006
study of the national heart, lung, and blood institute. Circulation 119, 3070-
7.
Leening MJ, Elias-Smale SE, Felix JF, Kors JA, Deckers JW, Hofman A, Stricker
BH, Witteman JC (2010). Unrecognised myocardial infarction and long-term
risk of heart failure in the elderly: the Rotterdam Study. Heart 96, 1458-62.
Leri A, Kajstura J, Anversa P (2011). Role of cardiac stem cells in cardiac
pathology: a paradigm shift in human myocardial biology. Circ Res 109: 941-
61.
Levitan EB, Wolk A, Mittleman MH (2009a). Relation of consistency with the
dietary approaches to stop hypertension diet and incidence of heart failure in
men aged 45 to 79 years. Am J Cardiol 104(10): 1416-20.
Levitan EB, Wolk A, Mittleman MH (2009b). Consistency with the DASH diet and
incidence of heart failure. Arch Intern Med 169(9): 851-7.
Levitan EB, Wolk A, Mittleman MA (2009c). Fish consumption, marine omega-3
fatty acids, and incidence of heart failure: a population-based prospective
study of middle-aged and elderly men. Eur Heart J 30, 1495-500.
Levy D, Anderson KM, Savage DD, Kannel WB, Christiansen JC, Castelli WP
(1988). Echocardiographically detected left ventricular hypertrophy:
prevalence and risk factors. The Framingham Heart Study. Ann Intern Med
108, 7-13.
Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP (1990). Prognostic
implications of echocardiographically determined left ventricular mass in the
Framingham Heart Study. N Engl J Med 322, 1561-6.
Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK (1996). The progression from
hypertension to congestive heart failure. JAMA 275, 1557-62.
Levy D, Kenchaiah S, Larson MG, Benjamin EJ, Kupka MJ, Ho KK, Murabito JM,
Vasan RS (2002). Long-term trends in the incidence of and survival with
heart failure. N Engl J Med 347, 1397-402.
Lieb W, Xanthakis V, Sullivan LM, Aragam J, Pencina MJ, Larson MG, Benjamin
EJ, Vasan RS (2009). Longitudinal tracking of left ventricular mass over the
adult life course: clinical correlates of short- and long-term change in the
framingham offspring study. Circulation 119, 3085-92.
Liebo MJ, Israel RL, Lillie EO, Smith MR, Rubenson DS, Topol EJ. (2011) Is
pocket mobile echocardiography the next-generation stethoscope? A crosssectional
comparison of rapidly acquired images with standard transthoracic
echocardiography. Ann Intern Med 155: 33-38.
Lindholm LH, Ibsen H, Dahlof B, Devereux RB, Beevers G, De Faire U, Fyhrquist
F, Julius S, Kjeldsen SE, Kristiansson K, Lederballe-Pedersen O, Nieminen
MS, Omvik P, Oparil S, Wedel H, Aurup P, Edelman J, Snapinn S (2002).
Cardiovascular morbidity and mortality in patients with diabetes in the
Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a
randomised trial against atenolol. Lancet 359, 1004-10.
Lloyd-Jones DM, Larson MG, Leip EP, Beiser A, D'agostino RB, Kannel WB,
Murabito JM, Vasan RS, Benjamin EJ, Levy D (2002). Lifetime risk for
developing congestive heart failure: the Framingham Heart Study. Circulation
106, 3068-72.
Loehr LR, Rosamond WD, Chang PP, Folsom AR, Chambless LE (2008). Heart
failure incidence and survival (from the Atherosclerosis Risk in Communities
study). Am J Cardiol 101, 1016-22.
Loehr LR, Rosamond WD, Poole C, Mcneill AM, Chang PP, Deswal A, Folsom AR,
Heiss G (2010). The potentially modifiable burden of incident heart failure
due to obesity: the atherosclerosis risk in communities study. Am J Epidemiol
172, 781-9.
Macheret F, Boerrigter G, Mckie P, Costello-Boerrigter L, Lahr B, Heublein D,
Sandberg S, Ikeda Y, Cataliotti A, Bailey K, Rodeheffer R, Burnett JC, Jr.
Pagina 106 van 122